TriMas (TRS)
(Delayed Data from NSDQ)
$26.18 USD
+1.31 (5.27%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $26.21 +0.03 (0.11%) 7:58 PM ET
5-Strong Sell of 5 5
C Value D Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$26.18 USD
+1.31 (5.27%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $26.21 +0.03 (0.11%) 7:58 PM ET
5-Strong Sell of 5 5
C Value D Growth A Momentum D VGM
Zacks News
Century (CENX) Up 6.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Century (CENX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TriMas (TRS) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
TriMas (TRS) delivered earnings and revenue surprises of -34.43% and 11.41%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
TriMas (TRS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
TriMas (TRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Worthington Industries (WOR) Lags Q1 Earnings Estimates
by Zacks Equity Research
Worthington (WOR) delivered earnings and revenue surprises of -7.47% and 14.71%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?
TriMas (TRS) Q2 Earnings Meet Estimates
by Zacks Equity Research
TriMas (TRS) delivered earnings and revenue surprises of 0% and 0.52%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
TriMas (TRS) Stock Declines 29% YTD: Is Revival Likely?
by Zacks Equity Research
Escalating raw material costs for resin-based raw materials, components and certain types of steel and supply-chain constraints are impacting TriMas' (TRS) price performance.
TriMas (TRS) Wins Boeing T-7A Contract, Boosts Defense Business
by Zacks Equity Research
TriMas (TRS) wins a multi-year contract from Boeing to supply components for Boeing's T-7A Red Hawk training jet program.
TriMas (TRS) Q1 Earnings Meet Estimates
by Zacks Equity Research
TriMas (TRS) delivered earnings and revenue surprises of 0% and 4.01%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
TriMas (TRS) Up 0.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
TriMas (TRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TriMas (TRS) Q4 Earnings Surpass, Sales Matches Estimates
by Zacks Equity Research
TriMas (TRS) Q4 top line gains on higher organic growth, acquisition-related sales and impacts of customers' stocking orders in the Aerospace group and robust demand in the Specialty Products group.
TriMas (TRS) Q4 Earnings Top Estimates
by Zacks Equity Research
TriMas (TRS) delivered earnings and revenue surprises of 5.66% and 0.25%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Timken (TKR) Q4 Earnings Lag Estimates
by Zacks Equity Research
Timken (TKR) delivered earnings and revenue surprises of -15.22% and 2.54%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
TriMas (TRS) Closes Omega Buyout, Fortifies Packaging Business
by Zacks Equity Research
TriMas (TRS) completes its acquisition of Omega Plastics, the third addition to its packaging platform in two years.
TriMas (TRS) to Buy Omega & TFI, Expands Packaging & Aerospace
by Zacks Equity Research
TriMas' (TRS) buyouts help it expand its product offerings in the packaging and aerospace business.
TriMas (TRS) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
TriMas (TRS) delivered earnings and revenue surprises of -5.00% and -1.14%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
TriMas (TRS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
TriMas (TRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Barnes Group (B) to Gain From Strong End Markets Amid Woes
by Zacks Equity Research
Barnes Group (B) is poised to gain from strength across its businesses, solid operational execution, and shareholder-friendly policies. Weakness in aerospace aftermarket business remains a woe.
TriMas (TRS) Bets on Solid Demand for Packaging & Acquisitions
by Zacks Equity Research
TriMas (TRS) will benefit from increasing demand for products used in personal care and home care applications supported by increased global awareness for hygiene even when the pandemic fades.
Here's Why TriMas (TRS) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks.com featured highlights include: Walmart, Vertex Pharma, Medical Properties Trust, TriNet Group and TriMas Corp
by Zacks Equity Research
Zacks.com featured highlights include: Walmart, Vertex Pharma, Medical Properties Trust, TriNet Group and TriMas Corp
Rising P/E: A Trick to Land on 5 Winning Stocks
by Sanghamitra Saha
Want to try a different approach? Tap five stocks with increasing P/E ratios.
TriMas (TRS) Q2 Earnings Top Estimates, Revenues Lag, Up Y/Y
by Zacks Equity Research
TriMas' (TRS) Q2 revenues and earnings improve year over year on higher sales in all segments. Assuming this trend to continue, it expects earnings per share in the range of $2.15 to $2.30 in 2021.
TriMas (TRS) Beats Q2 Earnings Estimates
by Zacks Equity Research
TriMas (TRS) delivered earnings and revenue surprises of 8.77% and -2.16%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
TriMas (TRS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
TriMas (TRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TriMas (TRS) Packaging Segment Invests in Manufacturing Unit
by Zacks Equity Research
TriMas' (TRS) Packaging segment is building a technologically advanced facility in Ohio that will help support future growth, drive operational excellence, and lower lead times to customers.